Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 87 citing MARTIN: Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment.... (0.10 sec) 

Infusions of donor leukocytes to treat Epstein-Barr virus-associated …


EB Papadopoulos, M Ladanyi, D Emanuel, S … - New England Journal …, 1994 - content.nejm.org
Methods We studied five patients in whom EBV-associated lymphoproliferative disorders developed
after they received a T-cell-depleted allogeneic bone marrow transplant. Biopsy specimens were
immunophenotyped, subjected to the polymerase chain reaction to determine the origin ...
Cited by 597 - Related articles - BL Direct - All 4 versions

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi- …

- hematologylibrary.org
RE Curtis, LB Travis, PA Rowlings, G Socie, … - …, 1999 - bloodjournal.hematologylibrary.org
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation
(BMT) at 235 centers worldwide to examine the incidence of and risk factors for posttransplant
lymphoproliferative disorders (PTLD). PTLD developed in 78 recipients, with 64 cases ...
Cited by 318 - Related articles - BL Direct - All 8 versions

Epstein-Barr virus lymphoproliferation after bone marrow transplantation

- bloodjournal.org [PDF] 
MM Zutter, PJ Martin, GE Sale, HM Shulman, L Fisher, … - Blood, 1988 - Am Soc Hematology
. Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ...
Cited by 291 - Related articles - All 5 versions

[PDF] Allogenic bone marrow transplantation: current status and future directions


RJ O'Reilly - Blood, 1983 - Am Soc Hematology
THE LAST DECADE, marrow transplantation been shown to provide a means for curative of
a number of lethal congenital and disorders of the hematopoietic and lymphoid Marrow transplantation
is the treatment of aplastic anemia and has emerged as a highly approach to the ...
Cited by 294 - Related articles - All 3 versions

[PDF] The history and future ofT-cell depletion as graft-versus-host disease prophylaxis …


VT Ho, RJ Soiffer - history, 2001 - bloodjournal.hematologylibrary.org
Despite significant progress in the past 20 years, graft-versus-host disease (GVHD) remains
a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation
(HSCT). T-cell depletion (TCD) of the donor graft offers the potential for prevention of ...
Cited by 222 - Related articles - BL Direct - All 4 versions

Frequency of'chronic active Epstein-Barr virus infection'in a general medical …


D Buchwald, JL Sullivan, AL Komaroff - JAMA, 1987 - Am Med Assoc
Twenty-one percent of 500 unselected patients, aged 17 to 50 years, seeking primary care for
any reason were found to be suffering from a chronic fatigue syndrome consistent with "chronic
active Epstein-Barr virus (EBV) infection," They had been experiencing "severe" fatigue, ...
Cited by 163 - Related articles - All 3 versions

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: …

- pnas.org [PDF] 
JW Gratama, MA Oosterveer, FE Zwaan, … - Proceedings of the …, 1988 - National Acad Sciences
Page 1. Proc. Natl. Acad. Sci. USA Vol. 85, pp. 8693-8696, November 1988 Medical Sciences
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: Implications for
sites of viral latency (Epstein-Barr virus nuclear antigens/immunoblotting) ...
Cited by 155 - Related articles - All 9 versions

Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the …

- bloodjournal.org
KG Lucas, RL Burton, SE Zimmerman, J Wang, KG … - Blood, 1998 - Am Soc Hematology
Epstein-Barr virus-induced lymphoproliferative disease (EBV-LPD) is a serious and potentially
fatal complication after allogeneic stem cell transplantation (SCT). To evaluate levels of EBV
DNA in SCT patients, a semiquantitative polymerase chain reaction (PCR) assay was ...
Cited by 147 - Related articles - BL Direct - All 4 versions

The development of cellular immunity to Epstein-Barr virus after allogeneic bone …

- hematologylibrary.org [PDF] 
KG Lucas, TN Small, G Heller, B Dupont, RJ … - Blood, 1996 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 141 - Related articles - BL Direct - All 4 versions

Biology and adoptive cell therapy of Epstein-Barr virus-associated …


RJ O'Reilly, TN Small, E Papadopoulos, K … - Immunological …, 1997 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 117 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 

Go to Google Home - About Google - About Google Scholar

©2009 Google